1. Acceptable intakes established for N-nitrosamines , European Medicines Agency, 28 September 2023 EMA/315970/2023 rev.1, https://www.ema.europa.eu/en/documents/other/appendix-1-acceptable-intakes-established-n-nitrosamines_.pdf.
2. Analytical Procedures and Methods Validation for Drugs and Biologics Guidance for Industry, https://www.fda.gov/files/drugs/published/Analytical-Procedures-and-Methods-Validation-for-Drugs-and-Biologics.pdf,.
3. Development and validation of a UV spectrophotometric method for the simultaneous estimation of eprosartan mesylate and hydrochlorothiazide in bulk and formulations;Anandakumar;Indian J. Pharm. Sci.,2011
4. Mutagenicity of amine drugs and their products of nitrosation;Andrews;Mutation Research/genetic Toxicology,1984
5. Approaches and Considerations for the Investigation and Synthesis of N-Nitrosamine Drug Substance-Related Impurities;Ashworth,2023